US Stock MarketDetailed Quotes
RGC Regencell Bioscience
- 7.602
- -0.178-2.28%
Trading Nov 6 15:15 ET
98.93MMarket Cap-23037P/E (TTM)
8.030High6.660Low18.61KVolume7.520Open7.780Pre Close137.20KTurnover1.27%Turnover RatioLossP/E (Static)13.01MShares32.44052wk High12.03P/B11.12MFloat Cap3.03052wk Low--Dividend TTM1.46MShs Float59.000Historical High--Div YieldTTM17.61%Amplitude3.030Historical Low7.373Avg Price1Lot Size
About Regencell Bioscience Company
Regencell Bioscience Holdings Ltd. engages in the research, development, and commercialization of traditional Chinese medicine. It seeks the treatment of neurocognitive disorders and degeneration, specifically attention deficit and hyperactivity disorder and autism spectrum disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.
Company Profile
SymbolRGC
Company NameRegencell Bioscience
Listing DateJul 16, 2021
Issue Price9.50
Founded2014
CEOMr. Yat-Gai Au
MarketNASDAQ
Employees12
Fiscal Year Ends06-30
Address9/F, Chinachem Leighton Plaza, 29 Leighton Road, Causeway Bay, Hong Kong
CityHong Kong，China
ProvinceHK
CountryChina
Phone852-2155-0823
Company Executives
-
Name
- Position
- Salary
-
Yat-Gai Au
- Chief Executive Officer and Chairman of the Board
- --
-
Wai Hong James Chung
- Director, Chief Operating Officer and Chief Strategy Officer; Vice President, Regencell Bioscience Limited
- --
-
Yat-Pui Au
- Chief Business Officer; Senior Vice President, Regencell Bioscience Limited
- --
-
Yee Wah Evana Hui
- Independent Director
- --
-
Paul J. Niewiadoi
- Independent Director
- --
-
Dr. Wing Yan William Lo
- Independent Director
- --
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data